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variables (Y1 and Y2). The optimal formulation predicted by genetic algorithm (GA) combined with
the models was characterized by microscopy and nuclear magnetic resonance spectrometry, and the
stability of Doxy in the complex was evaluated. The highest values of Y1 and Y2 were obtained
using an ANN model combined with GA which predicted the values of X1–X4 to be 4, 10.8, 12 h
and 25 1C, respectively. The modeling and optimization results indicated that a feed-forward
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objective optimization of a pharmaceutical formulation.
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Doxycycline (Doxy) belongs to the tetracycline group of broad-
spectrum antibiotics. A number of formulations are available
including solid dosage forms such as pellets1 and liquid dosage
forms such as ophthalmic preparations2. However, the poor
stability of Doxy in aqueous solution is a major obstacle to the
widespread clinical application of ophthalmic preparations. The
aim of this study was to overcome this instability and prepare a
stable formulation of Doxy for ophthalmic delivery.
Hydroxypropyl-b-cyclodextrin (HP-b-CD) is well known for its
ability to stabilize molecules by forming drug-CD complexes3. In
addition, Doxy forms a chelate with magnesium ion which also
increases Doxy stability4. In a previous study5, we formulated a
Doxy-HP-b-CD inclusion complex in a thermally sensitive polox-
amer hydrogel which could be stored in the cold and would form
a hydrogel when applied to the surface of the eye. In the present
study, we investigated a solid Doxy-HP-b-CD(Mg2þ) inclusion
complex which could be dissolved before use and would remain
stable in aqueous solution for a week.
The concept of design of experiments (DOE) was introduced to
optimize the Doxy formulation in this study. The molar ratios of
HP-b-CD/Doxy (X1) andMg
2þ/Doxy (X2) together with inclusion
time (X3) and temperature (X4) were selected as independent
variables and inclusion efﬁciency (Y1) and stability of Doxy (Y2)
were identiﬁed as dependent variables (i.e., responses). Central
composite design (CCD) together with some advanced modeling
technologies provided a rational approach to the optimization
process. Response surface methodology (RSM) was also applied6,7
despite recognition of the fact that this polynomial approach is
limited in its application to multi-objective optimization of
formulations.
Two novel optimization techniques, artiﬁcial neural networks
(ANN) and support vector machine (SVM) modeling were applied
in this study. ANN is a computer program designed to simulate
the learning capabilities of neurological systems using different
learning algorithms8. Compared to RSM, ANN has prominent
advantages for modeling complex non-linear relationships and can
handle multiple independent and dependent variables simulta-
neously. For this reason, ANN has been successfully applied to
solve various problems in the development of drug delivery
systems9–12. SVM is a novel algorithm which can solve non-
linear problems by performing linear regression in a multi-
dimensional feature space. Due to its remarkable accuracy and
generalization performance, SVM has been extensively applied to
quantitative structure activity relationship (QSAR) studies in
recent years13,14.
As there are two response variables in the present study, a
multi-objective simultaneous optimization technique was
employed to transform the multi-objective problem into a single-
objective problem. However, since it is difﬁcult to minimize or
maximize all objective functions simultaneously using classical
optimization methods when objective functions are in a trade-offrelationship, the genetic algorithm (GA) approach was used. The
superior ability of GAs to determine the global optimum and to
carry out parallel computing of multi-objective functions has led
to an increasing number of applications in pharmaceutical and
related ﬁelds15,16. In this study, the use of GAs for global
optimization was combined with other modeling techniques in
GA-based approaches such as GA-ANN17,18 and GA-SVM19,20
to determine the composition of a Doxy-HP-b-CD(Mg2þ) for-
mulation with optimum inclusion efﬁciency and stability in
aqueous solution. This optimum formulation was further char-
acterized by microscopy and NMR spectroscopy21.
2. Materials and methods
2.1. Materials
Doxy monohydrate (Doxy H2O, purity 98.5%) and Doxy
hydrochloride (Doxy HCl, purity 92.5%) were kindly provided
by Yancheng Suhai Pharmaceutical Co., Ltd. (Jiangsu, China).
HP-b-CD was obtained from Roquette (Lestrem, France). All
other reagents were of analytical grade and used as received.
2.2. Preparation of Doxy-HP-b–CD(Mg2þ) complex
Thirty formulations of the Doxy-HP-b-CD(Mg2þ) complex
were prepared based on central composite design for RSM,
ANN and SVM analysis to determine relationships between
the selected independent and dependent variables. The 30
formulations included different molar ratios and process
parameters according to DOE. In all cases, Doxy H2O
containing 25 mg Doxy was added to aqueous magnesium
chloride solutions of different concentrations and magnetically
stirred at a speciﬁc temperature until equilibrium was attained.
Solutions were then ﬁltered through 0.45 mm membranes and
lyophilized to obtain the solid inclusion complexes.
2.3. Assay for Doxy
Doxy was assayed by HPLC using the method in the Chinese
Pharmacopoeia22. A Waters HPLC system was equipped with a
reversed-phase Luna C18 column (250 mm 4.6 mm, 5 mm,
Phenomenex, USA) maintained at 35 1C and a UV detector set
at 280 nm. The mobile phase consisted of 0.05 M ammonium
oxalate: dimethylformamide: 0.2 M diammonium phosphate 65:
30: 5, pH 8.070.2 delivered at a ﬂow rate of 1.0 mL/min. The
injection volume was 20 mL.
2.4. Determination of inclusion efﬁciency
Inclusion efﬁciency of Doxy was determined using molecular
sieve chromatography to separate free Doxy from the HP-b-CD
inclusion complex. Stirred solutions (0.5 mL) were added
Table 1 Experimental domain according to central com-
posite design and the measured responses for 30 different
formulations of the Doxy-HP-b-CD (Mg2þ) inclusion
complex.
Sample No. Factor Response
X1 X2 X3 X4 Y1 Y2 Y
Zhouhua Wang et al.132to columns (50 mm 10 mm) packed with Dextran (Sepha-
dexs G-10, International Specialty Products Inc.) and eluted
with water at a ﬂow rate of 0.65 mL/min. The ﬁrst 25 mL of
eluent was collected and analyzed for Doxy content. Inclusion
efﬁciency was calculated using the following equation:
Inclusion efficiency ð%Þ ¼ Amount of Doxy in eluate
Total amount of Doxy
 100% ð1Þ1 2.75 3.75 12 30 96.35 89.43 0.676
2 6.25 3.75 12 30 88.56 90.2 0.423
3 2.75 9.25 12 30 98.05 93.67 0.835
4 6.25 9.25 12 30 93.7 97.12 0.762
5 2.75 3.75 20 30 91.5 82.53 0.351
6 6.25 3.75 20 30 94.82 82.93 0.437
7 2.75 9.25 20 30 90.77 82.37 0.329
8 6.25 9.25 20 30 90.07 83.63 0.346
9 2.75 3.75 12 40 86.9 84.83 0.260
10 6.25 3.75 12 40 93.51 82.05 0.378
11 2.75 9.25 12 40 89.86 85.27 0.380
12 6.25 9.25 12 40 92.32 87.92 0.520
13 2.75 3.75 20 40 90.32 77.58 0.104
14 6.25 3.75 20 40 93.51 83.8 0.439
15 2.75 9.25 20 40 84.74 83.19 0.117
16 6.25 9.25 20 40 95.04 83.82 0.473
17 1 6.5 16 35 84.2 81.93 0.054
18 8 6.5 16 35 85.3 91.31 0.235
19 4.5 1 16 35 95.27 85.63 0.538
20 4.5 12 16 35 85.85 87.83 0.244
21 4.5 6.5 8 35 99.17 83.82 0.555
22 4.5 6.5 24 35 95.79 80.68 0.359
23 4.5 6.5 16 25 95.05 93.84 0.744
24 4.5 6.5 16 45 96.85 89.61 0.694
25 4.5 6.5 16 35 94.81 89.77 0.641
26 4.5 6.5 16 35 94.69 85.53 0.521
27 4.5 6.5 16 35 92.48 89.72 0.567
28 4.5 6.5 16 35 92.73 91.07 0.605
29 4.5 6.5 16 35 96.93 91.2 0.739
30 4.5 6.5 16 35 94.16 85.13 0.4962.5. Stability studies
A controlled sample of Doxy HCl was prepared with the same
concentration of Doxy (0.1%, w/w) as in the inclusion complex.
Solutions of Doxy HCl and the Doxy-HP-b-CD inclusion com-
plexes were then stored at 4072 1C and a relative humidity of
7575% for 10 days. Drug content was determined at the begin-
ning and after 5 and 10 days to determine the stability of Doxy.
2.6. DOE
A four-factor-ﬁve-level CCD was employed in STATISTICA
trial version 8.0 software (Statsoft Inc., Tulsa, Oklahoma).
Responses were measured in a total of 30 runs (Table 1) and
used for RSM, ANN and SVM modeling.
2.7. RSM
2.7.1. Selection of variables and generation of non-linear
model
Data relating to the two responses were ﬁtted to classical second-
and third-order polynomials. In the second-order polynomial
model
Y ¼ b0 þ
Xn
i ¼ 1
biXi þ
Xn1
i ¼ 1
Xn
j ¼ iþ1
bijXiXj þ
Xn
i ¼ 1
biiX
2
i ð2Þ
Y is the measured response and b0 is an intercept. The coefﬁcients
corresponding to linear effects (bi), interaction (bij) and quadratic
effects (bii) for the factors Xi and Xj were determined from the
results of experiments.
In the third-order polynomial model
Y ¼ b0 þ
Xn
i ¼ 1
biXi þ
Xn
i ¼ 1
Xn
j ¼ 1
bijXiXj
þ
Xn
i ¼ 1
Xn
j ¼ i
Xn
k ¼ j
bijkXiXjXk ð3Þ
Y and b0 are as above and bi, bij and bijk represent the
estimated coefﬁcients for the factors Xi, Xij and XiXjXk,
respectively.
Experimental data were analyzed by nonlinear estimation in
SAS version 9.0 (Cary, NC, USA). The value of R2 and the F-test
were used to identify the model with the best ﬁt and to evaluate
the lack of ﬁt within each model. In order to determine the most
stable and interpretable variables of the second- and third-order
polynomials, relevant variables were selected by forward and
backward methods. These methods can diminish the full equation
form by removing useless variables which have little impact on the
predictive ability of the model.2.7.2. Desirability function
In order to ﬁnd the optimum formulation, the multi-criteria
problem was treated as a single criterion problem by using the
desirability function approach23. In this study, the two
responses were targeted to maximum, and the desirability
function for the maximum response was deﬁned as:
di ¼
YiYmin
YmaxYmin
ð4Þ
where Ymin and Ymax represent the lowest and highest possible
values, respectively, and Yi indicates the experimental value.
Based on the observed response values, the limits were set as:
Y1/Ymax¼100.0, Y1/Ymin¼84.0; Y2/Ymax¼98.0, Y2/Ymin¼77.0.
After obtaining the individual desirability function for each
response, a global desirability function (D) was calculated by
combining the individual desirability functions using the geometric
mean as shown below.
D¼
Yk
i ¼ 1
di
 !1=k
ð5Þ
where k is the number of responses. The result of RSM1 means the
optimization based on the desirability function and RSM2 means
the optimization based on genetic algorithm.
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A three layer feed-forward back-propagation (BP) network
incorporating the four independent variables in the input layer
and the two response variables in the output layer was ﬁtted to
the data set according to CCD (Fig. 1). Ten nodes in the
hidden layer and the nodes in adjacent layers were fully
interconnected with links, the intensity of connection between
two nodes being described by a weight function. By summing
the input from the previous layer and implementing a transfer
function, the output of a node to the next layer was computed.
A popular transfer function is the logistic sigmoid function
described by the following equation:
f ðyjÞ ¼
1
1þ exp ða yjÞ
ð6Þ
Here f(yj) is the output from the jth neuron, a denotes the
slope of the sigmoidal function and yj is deﬁned as:
yj ¼
Xn
i ¼ 1
Wijxi þ Bj ð7Þ
where xi is the input to the ith node from the previous layer
with a total of n nodes, Wij is the corresponding weight and Bj
is a bias term. The logistic sigmoid and pure linear functions
were used as transfer functions in the hidden and output layers
of the ANN, respectively. The ANN was trained iteratively to
minimize the performance function of the mean square error
(MSE) between the results of the output neurons and the
actual outputs. After each cycle, the gradient of the perfor-
mance function of the MSE was used to adjust the network
weights and biases. Once the MSE reached 104, the training
was terminated and the corresponding ANN was built.
MATLAB version 7.9.0 (Mathworks Inc., Natick, MA,
USA) was employed in the development and training of
ANN. The initial weights and biases of the network were
generated automatically by the program.
2.9. SVM modeling
SVM, as developed by Cortes and Vapnik24, is a novel
machine learning method acquiring popularity due to some
appealing features and its promising empirical performance.
SVM was originally designed to handle classiﬁcation problems
but, with the introduction of the e-insensitive loss function, theFigure 1 Optimum neural network architecture based on central
composite design.application of SVM has been broadened to apply to non-
linear regression. The basic idea of SVM is to map the original
input data into a highly dimensional feature space using a
kernel function. Linear regression is then performed in this
feature space and the non-linear problem is resolved in a linear
space. The SVM model is described by the following function:
f ðxÞ ¼
Xl
i ¼ 1
ðai þ ani ÞKðxi;xÞ þ b ð8Þ
where xi is a feature vector corresponding to a training object
and b is a constant. The components of the vectors ai and ai
n
are the introduced Lagrange multipliers. For the kernel
function, K(xi, x), the Gaussian radial basis function in
Eq. 9 was selected due to its effectiveness and efﬁciency in
the training process.
Kðxi;xÞ ¼ exp 
JxixJ
2g2
 
ð9Þ
where g is the parameter of the kernel and xi and x are two
independent variables. LIBSVM software (available at http://
www.csie.ntu.edu.tw/cjlin/libsvm) was used to process the
SVM regression25.
2.10. Genetic algorithm (GA)
GA is used to search the solution space by simulated evolution
of ‘‘survival of the ﬁttest’’. GA can solve linear and nonlinear
problems through exploring all areas of state space and
exploiting potential regions by mutation, crossover and selec-
tion operations applied to individuals in the population26.
The evolutionary process of GA consists of three steps:
(1) initialization of the ﬁrst generation; (2) evaluation of
the ﬁtness of each individual by an objective function; and
(3) using genetic operators of parent selection, including
application of reproduction, crossover and mutation to pro-
vide the ﬁrst offspring generation. Iteration of step 2 and 3 is
performed until the objective function converges.
In this study, the optimization of the process was accom-
plished using the Shefﬁeld MATLAB Genetic Algorithm
Toolbox Version 1.2 in MATLAB (version 7.9.0)27.
2.11. Validation of models
In order to assess the reliability of the generated mathematical
models, optimized check point formulations were prepared
and evaluated for various responses. The experimental values
of the responses were quantitatively compared with the
predicted values to calculate the percentage of the prediction
bias. This is helpful in establishing the validity of generated
equations and describing the application domain of these
models.
2.12. Characterization of the optimum Doxy-HP-b-
CD(Mg2þ) complex
Based on the modeling results, the optimum formulation of
the Doxy-HP-b-CD(Mg2þ) inclusion complex was prepared
and characterized by microscopy and NMR analysis. A
physical mixture was also prepared for contrast analysis by
grinding together the appropriate mixture of Doxy, HP-b-CD
and MgCl2 in a quartz mortar.
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The morphology of samples was investigated using an inverted
microscope (Olympus, X71, Japan) operating at  400 mag-
niﬁcation. Solid samples of raw materials, the physical mixture
and inclusion complex were mounted directly onto glass slides
for analysis.2.12.2. NMR spectroscopy
1H NMR was performed using an Avanc III NMR spectro-
meter (Bruker, Germany) at 400 MHz. Samples containing the
equivalent of 10 mg Doxy were dissolved in CD3OD. Chemi-
cal shifts (d) are reported in ppm and referenced to the residual
CD3OD signal at 3.31 ppm.3. Results and discussion
3.1. RSM
3.1.1. Selection of variables and generation of non-linear
model
Using the second order polynomial model (Eq. 2), the
efﬁciency was unsatisﬁed as the R2 values for overall response
(Y) and the responses for inclusion efﬁciency (Y1) and stability
(Y2) were 0.8498, 0.8115, and 0.7861, respectively. The fact
that all are o0.9 indicates a lack of variability in this model
and the need for the more highly variable cubic equation
(Eq. 3). Comparing forward and backward methods based on
the R2 values shows that the backward method gives the
highest ﬁtting efﬁciency. Using the F-test to evaluate the lackFigure 2 Three dimensional response surface plots and two dimensio
Mg2þ/Doxy (X2), and (B) inclusion time (X3) and inclusion temperatur
CD/Doxy (X1) and Mg
2þ/Doxy (X2), and (D) inclusion time (X3) an
input factors were kept constant at mid-range values (HP-b-CD/D
temperature 35 1C).of ﬁt within each model gives Po0.0001 in all cubic equations
indicating the third order polynomial model generates a
signiﬁcantly better ﬁt.
Y ¼ 3:3800:138X40:045X1X10:112X1X20:047X1X3
þ0:052X1X4 þ 0:059X2X2 þ 0:035X2X30:020X2X4
0:002X3X3 þ 0:013X1X1X2 þ 0:006X1X1X3
0:005X1X1X40:0004X2X2X3 þ 0:0004X2X3X4
þ0:0002X2X4X4ðR2 ¼ 0:9603 F ¼ 22:59 Po0:0001Þ
ð10Þ
Y1 ¼ 133:70420:831X1 þ 8:140X22:554X1X2
þ0:812X1X3 þ 1:207X1X40:131X2X20:103X2X3
þ0:0464X3X30:220X3X40:0625X4X4
þ0:287X1X1X20:0762X1X1X40:0183X1X3X4
þ0:00478X3X4X4ðR2 ¼ 0:9090 F ¼ 10:71 Po0:0001Þ
ð11Þ
Y2 ¼ 83:681þ 10:616X31:856X4 þ 0:150X2X2
0:707X3X3 þ 0:102X1X1X1 þ 0:103X1X1X2
0:0643X1X1X40:0540X1X2X3 þ 0:0116X1X3X4
þ0:00587X1X4X40:00654X2X2X4 þ 0:00545X2X3X4
þ0:0124X3X3X3ðR2 ¼ 0:9059 F ¼ 11:85 Po0:0001Þ
ð12Þ
3.1.2. Response surfaceResponse surfaces were generated in order to understand the
effect of each variable on the responses. Fig. 2A–D shows thenal contour plots for (A) molar ratios of HP-b-CD/Doxy (X1) and
e (X4) versus inclusion efﬁciency (Y1) and (C) molar ratios of HP-b-
d inclusion temperature (X4) versus stability (Y2). The remaining
oxy 4.5; Mg2þ/Doxy 6.5; inclusion time: 16 h; and inclusion
Figure 3 Change of solution for Y1 and Y2 by GA-ANN.
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two-dimensional contour plot. Three-dimensional plots are
useful to describe interactions while contour plots are exceed-
ingly valuable when there is only one response. From the three
dimensional diagrams, it is easy to understand the interactions
between two independent variables and one dependent vari-
able. Fig. 2A and C shows the obtained surfaces are convex
and symmetrical suggesting the mole ratios (X1 and X2) are the
main factors inﬂuencing the responses Y1 and Y2. In Fig. 2B
and D, the ﬂat surfaces reveal that inclusion time (X3)
and inclusion temperature (X4) did not affect Y1 and Y2
signiﬁcantly.
3.2. ANN modeling
The model parameters of ANN were selected by trial and
error. According to the minimum validation, the optimum
network consisted of one hidden layer with 10 nodes, while the
number of training cycles or iterations was found to be 500.
To build a successful ANN model, the number of hidden
nodes is the key factor. Too few hidden nodes handicap the
learning capacity of the ANN model, while too many hidden
nodes may cause over-ﬁtting for the training data set. There
are several methods to determine the number of neurons in a
hidden layer, such as using a formula or empirically by the
programmers. As a result, these methods are either stereo-
typed or subjective. Kolomogorov’s theory indicates that
hidden nodes with twice the number of input variables plus
one are adequate to compute an arbitrary continuous func-
tion28. Jadid and Fairbairn29 proposed an upper limit on the
number of hidden nodes. Carpenter and Hoffman30 intro-
duced an equation to deﬁne the number of nodes in the hidden
layer based on the number of inputs and outputs and the
number of training sets.
In this work, the optimal number of hidden units was
determined by the exhaustive method which sets out all
possible solutions and ﬁnds the answer to meet the conditions.
One to 20 neurons were used to explore one by one in the
network and then, according to the maximum value of R2, the
optimum network architecture was obtained. Finally, a net-
work consisting of four input and two output units, with 10
hidden units arranged in a single hidden layer was selected
(Fig. 1). On this basis, the R2 values for Y1 and Y2 were 0.9947
and 0.9721, respectively, indicating that a quality trained
model with appropriate predictive capability was constructed.
3.3. SVM modeling
The performance of SVM for regression depends on the
combination of several factors including the type of kernel
function, the Gaussian function parameter g, the e-insensitive
loss function e, and the capacity parameter C. First, the radial
basis function (RBF), which is commonly employed in many
studies because of its satisfactory performance and limited
number of parameters to be adjusted31, was chosen as the
kernel function to determine the sample distribution in the
mapping space. The corresponding g of the kernel function has
a major effect on the number of support vectors and is closely
connected with the performance of SVM and the training
time. The parameter e prevents the entire training set meeting
boundary conditions and allows the possibility of sparsity.The parameter C controls the trade-off between maximizing
the binding and minimizing the training error.
To determine the optimal values of the above parameters, a
grid search was performed on the original data set using
combinations of the parameters in the following ranges: e
0.01–0.15; C 5–30; g 0.1–3.0. Screening was performed using
an incremental step of 0.01 for all parameters. Based on the
thorough search, the optimal values of e, C and g suitable for
SVM modeling of the responses were respectively 0.1, 9.19,
2.14 for Y1 and 0.1, 11.31, 0.5 for Y2. The Y1 optimal model
gave a root mean square error (RMSE) of 0.4458 and R2 of
0.9723. Corresponding values for the Y2 model were 1.4100
and 0.9305, respectively. With these optimal parameters, the
SVM regression simulated the complicated nonlinear relation-
ship between the independent and dependent variables.3.4. Multi-objective optimization and GA
GA was employed to search for the optimum formulation
after the RSM, ANN and SVM models were developed.
Appropriate implementation of GA includes the following
three steps; deﬁnition of the ﬁtness function, deﬁnition and
implementation of the genetic representation, and deﬁnition
and implementation of the genetic operators. In the RSM
model, Eqs. 11 and 12 for Y1 and Y2 were used as ﬁtness
functions for GA parallel solving, and Eq. 10 for the global
response Y was used as the ﬁtness function to compute the
optimal value. In the ANN model, after obtaining the
relationship between the causal factors and the response
variables according to Eqs. 6 and 7, ANN generated a
nonlinear model as ﬁtness function for GA. In the SVM
model, according to Eq. 8, an integrated equation was
generated as ﬁtness function for GA.
The control parameters used in GA were set as follows:
population size 100; generations 500; precision of variables 20;
generation gap 0.9; crossover rate 0.4; and mutation rate 0.4.
Fig. 3 shows the change of solution for Y1 and Y2 by GA-
ANN. For the ANN data set, after 100 generations evolved,
the solutions of Y1 and Y2 not only became stable but also
reached the optimal result at the same generation. This clearly
indicates that GA possesses an excellent ability for parallel
computing and can effectively resolve the problem of multi-
objective optimization, which is better than classical optimiza-
tion methods.
Table 2 Experimental and predicted values of Y1 and Y2 for the optimum formulation of the Doxy-HP-b-CD(Mg
2þ) inclusion
complex as determined by RSM, ANN and SVM models.
Modeling method Factor Response Biasa (%)
Experimental Predicted
X1 X2 X3 X4 Y1 Y2 Y1 Y2 Y1 Y2
RSM1 3.0 9.0 16.0 32.5 0.79170.01 (Y) 0.847 (Y) 7.08 (Y)
RSM2 3.5 11.2 10.0 30.0 93.2572.18 87.4973.15 96.60 92.75 3.59 6.02
ANN 4.0 10.8 12.0 25.0 99.1971.24 95.5471.51 99.75 97.44 0.57 1.99
SVM 3.7 9.3 12.5 26.5 98.0571.92 91.5371.89 99.09 96.72 1.06 5.67
aBias (%)¼(predicted valueexperimental value)/experimental value 100.
Figure 4 Micrographs of Doxy/HP-b-CD systems. (A) Doxy; (B) HP-b-CD; (C) physical mixture of Doxy/HP-b-CD (Mg2þ) and (D)
inclusion complex of Doxy/HP-b-CD (Mg2þ).
Figure 5 1H NMR spectra. (A) Doxy and (B) inclusion complex of Doxy/HP-b-CD(Mg2þ) in CD3OD.
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Optimization of a doxycycline hydroxypropyl-b-cyclodextrin inclusion complex based on computational modeling 137The optimum formulation generated by three models and
the corresponding responses are summarized in Table 2.
Values of X1–X4 for the optimum formulation obtained from
the ANN model were 4, 10.8, 12 h and 25 1C, respectively.3.5. Comparison of RSM, ANN and SVM modeling
Comparing the modeling performance of the three methods,
ANN deﬁnitely produced the greatest R2 values (0.9947 for Y1
and 0.9721 for Y2). This indicates that ANN based on non-linear
modeling with high variability of neuron connections is the most
appropriate method to model a complicated system with multiple
factors and responses. In contrast, RSM showed a lack of
variability in R2 values (0.9090 for Y1, 0.9059 for Y2) due to the
limitations of regression equations. Interestingly, SVM with its
limited previous application to formulation optimization showed
good modeling in terms of R2 values (0.9723 for Y1 and 0.9305 for
Y2) because of its relatively high variability for non-linear
modeling. However, compared to ANN, SVM is probably more
suitable for handling classiﬁcation problems.
In view of the percentage bias in the experimental data
(Table 2), RSM1 based on the desirability function showed
relatively poor prediction (7.08% bias for Y) presumably
reﬂecting a defect of this traditional unitary method. RSM2
based on GA optimization yielded better prediction (3.59%
bias for Y1 and 6.02% bias for Y2) than RSM1 reﬂecting the
excellent ability of GA for parallel computing. The reason
SVM yielded better prediction (1.06% bias for Y1 and 5.67%
bias for Y2) than RSM can be ascribed to the relatively higher
level of generalization of SVM for non-linear modeling.
However, the lowest percentage bias (0.57% for Y1 andTable 3 1H NMR chemical shifts of Doxy and Doxy-HP-
b-CD(Mg2þ) in CD3OD at 20 1C.
Hydrogen dDoxy dDoxy/HP-b-CD(Mg2þ) Dd
a
7-H 6.95 6.98 0.03
8-H 7.48 7.53 0.05
9-H 6.84 6.87 0.03
4-N(CH3)2 2.75 2.71 0.04
6-CH3 1.55 1.58 0.03
aDd¼dDoxy/HP-b-CD(Mg2þ)dDoxy.
Table 4 Stability of aqueous solutions of the Doxy-HP-b-CD in
Sample Time (day) Appearance
Doxy HCl (Control) 0 Light yellow clear
5 Light brown minor de
10 Brown more depositio
Doxy/HP-b-CD 0 Light yellow clear
5 Light yellow clear
10 Yellow minor deposit
Doxy/HP-b-CD(Mg2þ) 0 Light yellow clear
5 Light yellow clear
10 Yellow minor deposit1.99% for Y2) was obtained by the ANN method, convin-
cingly indicating the validity of the generated model.
3.6. Characterization of the optimum HP-b-CD Doxy inclusion
complex
3.6.1. Microscopic observation
Microscopic examination of pure materials, the physical mixture
and the optimum inclusion complex are shown in Fig. 4. Doxy
(Fig. 4A) appears as club-shaped crystals whereas HP-b-CD
(Fig. 4B) exhibits amorphous spherical particles. In the physical
mixture (Fig. 4C), Doxy crystals and HP-b-CD particles are
clearly observed, indicating the absence of a host-guest interaction.
In contrast, the Doxy-HP-b-CD (Mg2þ) inclusion complex
(Fig. 4D) is in the form of irregular particles of variable size with
completely different morphologies from Doxy and HP-b-CD
supporting the formation of an inclusion complex.
3.6.2. NMR spectroscopy
Since Doxy is hydrophobic and has low aqueous solubility, it
can be encapsulated in the hydrophobic cavity of HP-b-CD.
When inclusion occurs, the changes in the physical and
chemical environment affects the electronic density of Doxy
hydrogen atoms which can be detected by NMR. Given the
limited aqueous solubility of Doxy, NMR was performed on
solutions of drug and inclusion complex in CD3OD
32,33. The
1H NMR spectra of Doxy and its inclusion complex using a
molar ratio of 1:4 are shown in Fig. 5 with corresponding
proton shifts summarized in Table 3. As shown in Fig. 5B,
proton shifts for H7, H8, H9, 4-N(CH3)2 and 6-CH3 of Doxy
are clearly observed in the complex suggesting a deep
penetration of the Doxy molecule into the cavity of HP-b-CD.
3.7. Stability studies
As shown in Table 4 and Fig. 6, Doxy HCl degraded rapidly
at 40 1C with the sample changing from yellow to brown and
the amount of related substance increasing signiﬁcantly. In
contrast, the stability of Doxy in the Doxy-HP-b-CD and
Doxy-HP-b-CD (Mg2þ) complexes was higher as shown by
less color change (Fig. 6) and formation of less related
substances (Table 4). The results indicate that the formation
of an inclusion complex in the presence of Mg2þ enhances the
stability of Doxy to the greatest extent. This is probablyclusion complex stored at 4072 1C for 10 days (n¼3).
Doxy content (%) Related substance (%)
100.00 0.9371.55
position 91.2070.75 5.5272.23
n 83.1074.21 9.5070.62
100.00 0.7370.15
93.2171.57 3.6370.27
ion 88.6773.61 6.4170.53
100.00 0.6570.06
98.9371.24 1.4370.44
ion 95.5471.51 5.9070.34
Figure 6 Changes in the appearance of solutions of (A) Doxy HCl, (B) the Doxy-HP-b-CD complex and (C) the Doxy-HP-b-CD
(Mg2þ) complex solution on storage at 40 1C over 10 days.
Zhouhua Wang et al.138because (1) Mg2þ and Doxy formed a chelate at the site of the
phenol diketone which protects Doxy from hydrolysis and (2)
Doxy is embedded in the HP-b-CD cavity in such a way that
its sensitive groups are protected.4. Conclusions
ANN with one hidden layer and 10 hidden units showed the best
modeling and prediction for inclusion efﬁciency and stability of
the Doxy-HP-b-CD (Mg2þ) inclusion complex. The optimal
formulation of the complex was obtained by a GA-ANN method.
Its formation was supported by NMR spectroscopy and it was
shown to stabilize Doxy in aqueous solution. Overall the results
show that a GA-based approach is a powerful tool for optimizing
pharmaceutical formulations in a cost and time efﬁcient manner.Acknowledgments
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